Third View Private Wealth
PFE icon

Third View Private Wealth’s Pfizer PFE Stock Holding History

Third View Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$483K Buy
16,939
+923
+6% +$24.5K 0.06% 178
2026
Q2 		$386K Sell
16,016
-555
-3% -$14.5K 0.05% 217
2026
Q1 		$465K Buy
16,571
+562
+4% +$15K 0.06% 172
2025
Q4 		$399K Buy
+16,009
New +$404K 0.05% 195

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Third View Private Wealth's PFE Position: Q3 2026 in Review

Third View Private Wealth increased its Pfizer (PFE) stake by 5.8% in Q3 2026, buying an estimated $24.5K and bringing the position to 16,939 shares worth $483K. The position accounts for 0.06% of the portfolio, ranked #178.

Third View Private Wealth first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Third View Private Wealth held 16,939 shares of Pfizer worth $483K as of Q3 2026.
  • Third View Private Wealth bought 923 Pfizer shares in Q3 2026, an estimated $24.5K.
  • Pfizer made up 0.06% of Third View Private Wealth's portfolio in Q3 2026, its #178 holding.
  • Third View Private Wealth first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Third View Private Wealth's 13F filing for Q3 2026, filed 30 Oct 2026.